These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
779 related articles for article (PubMed ID: 22886119)
1. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital. Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119 [TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Khan LM; Al-Harthi SE; Saadah OI Saudi Pharm J; 2013 Jul; 21(3):261-6. PubMed ID: 23960842 [TBL] [Abstract][Full Text] [Related]
3. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F; Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220 [TBL] [Abstract][Full Text] [Related]
4. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system. Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235 [TBL] [Abstract][Full Text] [Related]
6. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396 [TBL] [Abstract][Full Text] [Related]
7. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center. Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL Therapie; 2014; 69(5):395-400. PubMed ID: 25269141 [TBL] [Abstract][Full Text] [Related]
8. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL; Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210 [TBL] [Abstract][Full Text] [Related]
9. Detection of adverse drug reactions through the minimum basic data set. Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432 [TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006]. Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232 [TBL] [Abstract][Full Text] [Related]
11. [A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients.]. Esteban Jiménez Ó; Navarro Pemán C; González Rubio F; Lanuza Giménez FJ; Montesa Lou C Rev Esp Salud Publica; 2017 Dec; 91():. PubMed ID: 29269726 [TBL] [Abstract][Full Text] [Related]
12. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. Geer MI; Koul PA; Tanki SA; Shah MY J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493 [TBL] [Abstract][Full Text] [Related]
13. Developing an adverse drug reaction reporting system at a teaching hospital. Baniasadi S; Fahimi F; Shalviri G Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions experience in a teaching hospital in Jordan. Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening]. Yang W; Xiang YY; Xie YM; Shen H Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322 [TBL] [Abstract][Full Text] [Related]
16. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
17. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Tandon VR; Mahajan V; Khajuria V; Gillani Z Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314 [TBL] [Abstract][Full Text] [Related]
18. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study. Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890 [TBL] [Abstract][Full Text] [Related]
19. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions profile of antimicrobials: A 3-year experience, from a tertiary care teaching hospital of India. ; Tandon VR; Sharma S; Khajuria V; Mahajan V; Gillani Z Indian J Med Microbiol; 2015; 33(3):393-400. PubMed ID: 26068342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]